Q4 growth in medical cannabis while sonsumer segment declines materially
Added on 21 June 2024
![Q4 growth in medical cannabis while sonsumer segment declines materially Q4 growth in medical cannabis while sonsumer segment declines materially](/img/3003_4223_Q4_growth_in_medical_cannabis_while_sonsumer_segment_declines_materially.jpg)
The firms fiscal year 2023 notably consisted of only three quarters as a result of modifying the fiscal year. The results are for the period ended March 31, 2024.
Revenue during the quarter was largely attributable to the medical segment, which posted 20% growth year over year, ending the quarter at $45.6 million. Consumer cannabis meanwhile declined by 29%, falling to $10.2 million. Plant propagation fell by a less dramatic 3%, to produce revenues of $10.4 million during the quarter.
A total of 15,179 kilograms of cannabis were sold during the period, an 8% decline year over year, while the average net price of cannabis, excluding bulk sales, improved 13% to $5.37 per gram.
Photo by Ryan Lange on Unsplash
More news